These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21193343)

  • 1. Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial.
    Ondo WG; Shinawi L; Davidson A; Lai D
    Parkinsonism Relat Disord; 2011 Mar; 17(3):156-9. PubMed ID: 21193343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study.
    Merello M; Nouzeilles MI; Cammarota A; Leiguarda R
    Clin Neuropharmacol; 1999; 22(5):273-6. PubMed ID: 10516877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
    Lou JS; Dimitrova DM; Park BS; Johnson SC; Eaton R; Arnold G; Nutt JG
    Clin Neuropharmacol; 2009; 32(6):305-10. PubMed ID: 19620846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of memantine in dementia associated with Parkinson's disease.
    Leroi I; Overshott R; Byrne EJ; Daniel E; Burns A
    Mov Disord; 2009 Jun; 24(8):1217-21. PubMed ID: 19370737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease].
    Li W; Zhao JH; Sun SG; Zhang JW; Suo AQ; Ma MM
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):301-3. PubMed ID: 21419002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease.
    Hauser RA; Lyons KE; McClain T; Carter S; Perlmutter D
    Mov Disord; 2009 May; 24(7):979-83. PubMed ID: 19230029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly.
    Mace JL; Porter RJ; Dalrymple-Alford JC; Anderson TJ
    J Psychopharmacol; 2010 Apr; 24(4):615-9. PubMed ID: 19625388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and sleep disorders in Parkinson's disease.
    Scaravilli T; Gasparoli E; Rinaldi F; Polesello G; Bracco F
    Neurol Sci; 2003 Oct; 24(3):209-10. PubMed ID: 14598091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.
    Hauser RA; Schapira AH; Rascol O; Barone P; Mizuno Y; Salin L; Haaksma M; Juhel N; Poewe W
    Mov Disord; 2010 Nov; 25(15):2542-9. PubMed ID: 20669317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the clinical efficacy and safety of memantine for Huntington's disease.
    Ondo WG; Mejia NI; Hunter CB
    Parkinsonism Relat Disord; 2007 Oct; 13(7):453-4. PubMed ID: 17046312
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
    Lou JS; Kearns G; Benice T; Oken B; Sexton G; Nutt J
    Mov Disord; 2003 Oct; 18(10):1108-14. PubMed ID: 14534913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
    Kieburtz K;
    Mov Disord; 2011 Jan; 26(1):37-44. PubMed ID: 20925067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
    Möller JC; Oertel WH; Köster J; Pezzoli G; Provinciali L
    Mov Disord; 2005 May; 20(5):602-10. PubMed ID: 15726540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and behavioural impairment in Parkinson's disease.
    Merims D; Freedman M
    Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial.
    Yoritaka A; Takanashi M; Hirayama M; Nakahara T; Ohta S; Hattori N
    Mov Disord; 2013 Jun; 28(6):836-9. PubMed ID: 23400965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study.
    Moreau C; Delval A; Tiffreau V; Defebvre L; Dujardin K; Duhamel A; Petyt G; Hossein-Foucher C; Blum D; Sablonnière B; Schraen S; Allorge D; Destée A; Bordet R; Devos D
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):552-5. PubMed ID: 23077087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.